Current Affairs - Science - Discussion

Gepotidacin is a newly developed antibiotic that was first approved for the treatment of urinary tract infections (UTIs). It functions by inhibiting bacterial replication, which helps to combat bacterial infections effectively. Although it is now being explored as a potential treatment for drug-resistant gonorrhea—a significant development since no new treatments for gonorrhea have emerged since the 1990s—it was originally targeted for UTIs. Its oral form presents a major advancement over the current injectable treatments, making it more accessible and patient-friendly, especially in outpatient settings where ease of use is a crucial factor.